14 results match your criteria: "Center of Atherosclerosis[Affiliation]"

Introduction: Two of the main reasons recent guidelines do not recommend routine population-wide screening programs for asymptomatic carotid artery stenosis (AsxCS) is that screening could lead to an increase of carotid revascularization procedures and that such mass screening programs may not be cost-effective. Nevertheless, selective screening for AsxCS could have several benefits. This article presents the rationale for such a program.

View Article and Find Full Text PDF
Article Synopsis
  • A recent update was made about how to manage patients with asymptomatic carotid stenosis (AsxCS), which means they have a narrow artery but don’t show symptoms.
  • Researchers looked at studies until August 2023 to learn about new treatments and techniques for these patients.
  • It's important to provide medical treatment to all patients, but some with specific risks may need surgery, and decisions should be based on individual needs and situations.
View Article and Find Full Text PDF

Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.

Prog Cardiovasc Dis

September 2022

Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK.

Article Synopsis
  • International guidelines recommend using statins, alone or with other medications, to lower LDL cholesterol in patients with asymptomatic or symptomatic carotid stenosis, as it significantly reduces risks of stroke and cardiovascular events.
  • The overview evaluates the effectiveness of various lipid-lowering agents, emphasizing that statins and PCSK9 inhibitors offer substantial benefits like stabilizing carotid plaques and lowering stroke rates, while non-statin options like ezetimibe and fibrates also help but to a lesser extent.
  • Despite potential side effects, the advantages of lowering LDL cholesterol for these patients outweigh the risks, leading to a recommendation for high-dose statin therapy for all individuals, regardless of their baseline LDL levels.
View Article and Find Full Text PDF

Effect of statins on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure has not been well elucidated. Purpose. To assess changes of NT-proBNP during short term use of simvastatin in patients with coronary heart disease (CHD) and chronic systolic heart failure.

View Article and Find Full Text PDF

Autoimmune nature of influenza atherogenicity.

Ann N Y Acad Sci

June 2005

Center of Atherosclerosis and Lipid Disorders, Chair of Cardiology, Mechnicov's State Medical Academy, Saint Petersburg, Russia.

It has been observed during influenza epidemics and in a number of population and clinical trials that this prevalent viral infection was associated with increased death rates from cardiovascular diseases. The clinical and experimental data that may explain accelerated coronary atherosclerosis in influenza infection with implications involving autoimmune mechanisms are analyzed in this article. Both cellular and humoral autoimmune modes could be proposed to participate in the onset or progression of atheromatous lesions due to influenza infection.

View Article and Find Full Text PDF

Inhibitors of 3-hydroxy-3methylglytaryl coenzyme A (HMG-CoA) reductase or statins are effective lipid lowering drugs widely used in cardiovascular disease. In the recent years, pleotropic effects of statins have been reported, which include anti-inflammatory and immunomodulatory properties. This review discusses the anti-inflammatory and immunomodulatory roles of statins and their possible use for the treatment of other inflammatory diseases or conditions with the involvement of the immune system.

View Article and Find Full Text PDF

Influenza, autoimmunity and atherogenesis.

Autoimmun Rev

February 2005

Mechnicov's State Medical Academy, The Center of Atherosclerosis and Lipid Disorders, Chair of Cardiology, 194291 pr. Kultury 4, CMSD-122, Saint Petersburg, Russia.

It has been observed during influenza epidemics and in a number of population and clinical trials that this prevalent viral infection was associated with increased death rates from cardiovascular diseases. The clinical and experimental data that may explain accelerated coronary atherosclerosis in influenza infection with implications involving autoimmune mechanisms are reviewed in this article. Both cellular and humoral autoimmune mode could be proposed to participate in the onset or progression of atheromatous lesions due to influenza infection.

View Article and Find Full Text PDF

Unlabelled: Long term heart rate variability is used for prediction of sudden cardiac death (SD). There are simpler methods of assessment of autonomic cardiac control - registration of heart rate response to reflex tests and determination of heart rate variability (HRV) on short ECG recordins. Comparative value for prognosis of SD after myocardial infarction (MI) of these 3 techniques has not been studied yet.

View Article and Find Full Text PDF

Aim: To analyze relationship between changes of lipid levels and parameters of hemostasis and inflammation in a previously reported comparative study of some biological effects of pravastatin and atorvastatin in patients with non ST elevation acute coronary syndrome (NSTEACS).

Methods: Ninety aspirin and heparin treated patients with NSTEACS were randomized to open pravastatin 40 mg/day (n=31) and atorvastatin 10 (n=30) or 40 mg/day (n=29). At baseline, on days 7 and 14 we measured levels of thrombin-antithrombin complex (TAT), prothrombin fragments 1+2 (F1+2), D-dimer, von Willebrand factor (vWF) and C-reactive protein (CRP) and assessed platelet aggregation.

View Article and Find Full Text PDF

Background: Low heart rate variability (HRV) reflecting predominance of sympathetic tone is an independent predictor of sudden cardiac death after myocardial infarction (MI). We have previously shown that decreased heart rate (HR) response during reflex tests (breathing 6 per minute and Valsalva maneuver at the end of the first week after MI is also associated with elevated risk of sudden death during subsequent 2 years.

Aim: To elucidate relationship between HR response to breathing 6 per minute and Valsalva maneuver, and HRV as standard non-invasive method of assessment of autonomic regulation of the heart.

View Article and Find Full Text PDF

[Register of acute coronary syndromes in Russia: treatment and in hospital outcomes in non-ST elevation acute coronary syndrome].

Kardiologiia

July 2004

Research Institute for Physicochemical Medicine, Center of Atherosclerosis, ul. Malaya Pirogovskaya 1a, 119828 Moscow, Russia.

Data from about 50 consecutive patients with acute coronary syndromes aged > or =18 years admitted to 59 hospitals in different Russian cities were collected between November 2000 and July 2001. In addition to presumably ischemic symptoms within previous 24 hours they were to have ischemic ECG changes, documented coronary heart disease or positive markers of myocardial necrosis. Of 2806 patients included into registry 1394 (49.

View Article and Find Full Text PDF

Unlabelled: Levels of some markers of coagulation and platelet activation such as prothrombin fragment 1+2 (F1+2) thrombin-antithrombin complex (TAT) and von Willebrand factor (vWF), are related to outcome in non ST-segment elevation acute coronary syndrome (NSTEACS). Effects of thienopyridines ticlopidine and clopidogrel on acute changes of these parameters in patients with NSTEACS are not well investigated.

Aim: To study changes of markers of coagulation and platelet activation during short term use of ticlopidine and clopidogrel in NSTEACS patients treated with aspirin and antithrombin.

View Article and Find Full Text PDF

Background: The main aims of the Brisighella Terme Project are: 1. evaluation of feasibility and effectiveness of preventive medicine intervention in thermal ambient; 2. identification of subjects with cardiovascular risk factors; 3.

View Article and Find Full Text PDF